Xenon Pharmaceuticals Inc. announced Michael Hayden, who is not standing for reelection at this meeting. Michael has been instrumental to Xenon's success as a Co-Founder, Chief Scientific Officer for many years and long-standing member of Board. On behalf of the entire Xenon family, I'd like to Michael for his over 25 years of loyalty and dedication to the corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.24 USD | +1.49% | -0.52% | -16.98% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.98% | 2.84B | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |
- Stock Market
- Equities
- XENE Stock
- News Xenon Pharmaceuticals Inc.
- Xenon Pharmaceuticals Inc. Announces Michael Hayden Will Not Stand for Re-Election as Member of Board